rss
Br J Ophthalmol 87:753-757 doi:10.1136/bjo.87.6.753
  • Original Article
    • Clinical science

The effects of dorzolamide on choroidal and retinal perfusion in non-exudative age related macular degeneration

Table 4

FA analysis results

Area Treatment (number of subject) Mean AVP time (s) Standard error p Value
Superior temporal Placebo (12) 2.048 8.115
Superior temporal Dorzolamide (5) −20.937 19.327 0.2081
Inferior temporal Placebo (12) −0.464 10.261
Inferior temporal Dorzolamide (5) −18.972 17.627 0.3574
Combine superior and inferior Placebo (12) 0.074 6.334
Combine superior and inferior Dorzolamide (5) −20.546 18.111 0.1884

This Article

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.